KARAKTERISTIK PASIEN COVID-19 YANG MEMBUTUHKAN VENTILATOR DI INTENSIVE CARE UNIT

Anindia Salwa Salsabila; Beni Indra; Russilawati Russilawati

doi:10.55681/sentri.v3i7.3127

Authors

Anindia Salwa Salsabila Universitas Andalas
Beni Indra Universitas Andalas
Russilawati Universitas Andalas

DOI:

https://doi.org/10.55681/sentri.v3i7.3127

Keywords:

Karakteristik, COVID-19, Intensive Care Unit, ventilator

Abstract

Pasien Covid-19 dapat jatuh ke kondisi berat dan kritis yang membutuhkan perawatan suportif dan agresif di ICU dengan alat bantu pernapasan ventilator. Penelitian ini bertujuan untuk mengetahui karakteristik pasien Covid-19 yang membutuhkan ventilator di ICU RSUP Dr. M. Djamil Padang. Penelitian ini merupakan deskriptif observasional dengan pendekatan retrospektif menggunakan rekam medis dengan teknik pengambilan convenience sampling. Sampel penelitian ini adalah pasien yang dirawat dari Januari hingga Agustus 2021 yang memiliki rekam medis lengkap. Penelitian ini menganalisis 155 pasien, sebagian besar kelompok usia 50-69 tahun (60%), laki-laki (51.6%) memiliki komorbid DM tipe 2 (69%) dan hipertensi (52.9%). Gejala klinis terbanyak yang ditemukan adalah sesak napas (98.7%), demam (86.4%) dan batuk berdahak (65.8%). Pemeriksaan laboratorium didapatkan pasien dengan peningkatan nilai leukosit (87.7%), neutrofil (98.7%), D-dimer (100%), SGOT (75.5%), SGPT (58.7%), dan penurunan limfosit (97.4%). Seluruh pasien mengalami ARDS. Pemeriksaan marker inflamasi didapatkan peningkatan nilai ferritin (92.3%), prokalsitonin (100%), dan IL-6 (98.1%). Sebanyak 89.7% pasien dengan ventilator meninggal dengan 66.5% memakai ventilator kurang dari 10 hari. Sebagian besar pasien Covid-19 yang membutuhkan ventilator merupakan kelompok usia tua, laki-laki, memiliki komorbid DM tipe 2 dan hipertensi, mengalami peningkatan nilai D-dimer dan marker inflamasi, sehingga perlu memberikan perhatian dan observasi khusus pada kelompok pasien ini.

Downloads

Download data is not yet available.

References

Burhan E, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Tatalaksana COVID-19. In: Pedoman Tatalaksana Covid-19. 3rd ed. Jakarta: PDPI, PERKI, PAPDI, PERDATIN, IDAI; 2020;1-21.

World Health Organization. Coronavirus (COVID-19) Dashboard. 2022. [Last accessed on 2022 March 24]. Available from: https://www.who.int/emergencies/diseases/novel-corona virus -2019.

Komite Penanganan Covid-19 dan Pemulihan Ekonomi Nasional. Peta Sebaran COVID-19. 2022. [Last accessed on 2022 March 24]. Available from: https://covid19.go.id/peta-sebaran-covid19.

Pemerintah Provinsi Sumatera Barat. Daftar Publikasi Berita Corona. 2021. [Last accessed on 2022 March 24]. Available from: https://corona.sumbarprov.go.id/details/ index_master_berita.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109(2):102433.

Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–55.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.

Kelly D. Non–Invasive mechanical ventilation. Handb ICU Ther Second Ed. 2020;4(2):93–104.

Duan G. Intuition on virology, epidemiology, pathogenesis, and control of COVID-19. Nov Res Microbiol J. 2020;4(5):955–67.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA - J Am Med Assoc. 2020;323(16):1612–4.

Tonetti T, Zanella A, Pizzilli G, Irvin Babcock C, Venturi S, Nava S, et al. One ventilator for two patients: Feasibility and considerations of a last resort solution in case of equipment shortage. Thorax Med J. 2020;75(6):517–9.

RSUP M. Djamil Padang. Informasi Publik RSUP M. Djamil Padang. Rumah Sakit Umum Pusat Dr. M. Djamil Padang. 2021. [Last Accessed on 2021 July 20]. Available from: https://rsdjamil.co.id/informasi-publik/.

Allegra A, Di Gioacchino M, Tonacci A, Musolino C, Gangemi S. Immunopathology of SARS-CoV-2 infection: Immune cells and mediators, prognostic factors, and immune-therapeutic implications. Int J Mol Sci. 2020;21(13):1–19.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Sci. 2020;63(3):457–60.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.

Thompson BT, Chambers RC, Liu KD. Ards nejm 2017. Nejm J. 2017; 243(3);243-5

Meyer NJ, Christie JD. Genetic heterogeneity and risk of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2018;34(4):459–74.

Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35(3):266–71.

Alsharif W, Qurashi A. Effectiveness of COVID-19 diagnosis and management tools: A review. Radiography J. 2021;27(2):682–7.

Chaimayo C, Kaewnaphan B, Tanlieng N, Athipanyasilp N, Sirijatuphat R, Chayakulkeeree M, et al. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virol J. 2020;17(1):1–7.

Fenollar F, Bouam A, Ballouche M, Fuster L, Prudent E, Colson P, et al. Evaluation of the panbio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19. J Clin Microl. 2021;59(2):19–21.

Scohy A, Anantharajah A, Bodéus M, Kabamba MB, Verroken A, Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129(5):21.

Levani, Prastya, Mawaddatunnadila. Coronavirus disease 2019 (COVID- 19): patogenesis, manifestasi klinis dan pilihan Terapi. J Kedokt dan Kesehat. 2021;17(1):44–57.

Rello J, Belliato M, Dimopoulos MA, Giamarellos BEJ, Jaksic V, Martin LI, et al. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesth Crit Care Pain Med. 2020;39(6):723–30.

Sugiyono. Metode Penelitian Kuantitatif, Kualitatif, dan R&D. 1st Ed. Bandung: Alfabeta; 2017;23.

Zhang J, Cao Y, Tan G, Dong X, Wang B, Lin J, et al. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy Eur J Allergy Clin Immunol. 2021;76(2):533–50.

Mughal MS, Kaur IP, Jaffery AR, Dalmacion DL, Wang C, Koyoda S, et al. COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictor of the disease severe. Respi Med. 2020;172(6):106-32.

Nicola M, Di D, Calcaterra I, Lupoli R, Storino A, Spedicato GA, et al. Hemostatic changes in patients with COVID-19 : A meta-analysis with meta-regressions. Journal of Clinical Medicine. 2020;212(3):1–21.

Ferrando C, Suarez SF, Mellado AR, Hernández M, Gea A, Arruti E, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200–11.

Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis. PLoS One. 2021;16(22):1–16.

South AM, Brady TM, Flynn JT. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE inhibitor and Ang II (Angiotensin II) receptor blocker use during the pandemic: The pediatric perspective. Hypertension Med J. 2020;76(1):16–22.

Rajpal A, Rahimi L, Ismail-Beigi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes. 2020;12(12):895–908.

Mesquita RR, Junior FS, Santana SFM, Oliveira FT, Alcântara CR, Arnozo MG, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021;133(7–8):377–82.

Gao Y, Ding M, Dong X, Zhang J, Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Vol. 76, Allergy: European Journal of Allergy and Clinical Immunology. 2021. 428–55.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10):1054–62.

Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):131–4.

Mus R, Thaslifa T, Abbas M, Sunaidi Y. Studi literatur: tinjauan pemeriksaan laboratorium pada pasien COVID-19. J Kesehat Vokasional. 2021;5(4):242.

Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-6.

Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;5(22):123-6.

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle Region — Case Series. N Engl J Med. 2020;382(21):2012–22.

Schmidt M, Hajage D, Demoule A, Pham T, Combes A, Dres M, et al. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60–73.

Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–8.

Bezuidenhout MC, Wiese OJ, Moodley D, Maasdorp E, Davids MR, Koegelenberg CFN, et al. Correlating arterial blood gas, acid–base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients. Ann Clin Biochem. 2021;58(2):95–101.

Li S, Xiong J, Du Z, Lai W, Ma X, Feng Z, et al. Extracorporeal membrane oxygenation (ECMO) for critically ill patients with coronavirus disease 2019 (COVID-19): A retrospective cohort study. J Card Surg. 2021;36(10):3554–60.

Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. pulmonary and extra-pulmonary clinical manifestations of COVID-19. Front Med. 2020;7(8):1–12.

Ding Z, Li G, Chen L, Shu C, Song J, Wang W, et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol. 2021;74(6):1295–302.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA - J Am Med Assoc. 2020;323(20):2052–9.

Sjostrom A, Rysz S, Sjpstrom HHC. Electrolyte and acid-base imbalance in severe COVID-19. Endocr Connect. 2021;5(2):234.

Shengcong L, Long ZHW. Association between average plasma potassium levels and 30-day mortality during hospitalization in patients with COVID-19 in Wuhan, China. Int J Med Sci. 2021;3(20):327–9.

Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146(1):89.

Supit B. Prokalsitonin , d-dimer , dan ferritin sebagai prediktor perburukan COVID-19. 2021;48(11):357–60.

Garcia PDW, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, et al. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine. 2020;25(2):100-449.

Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13(6):1077–86.

Zheng Y, Sun LJ, Xu M, Pan J, Zhang YT, Fang X L, et al. Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China. J Zhejiang Univ Sci B. 2020;21(5):378–87.

Tian D, Sun Y, Zhou Jianming, Ye Q. The global epidemic of the SARS-CoV-2 delta variant, key spike mutations and immune escape. Front Immunol. 2021;12(75):178–9.

Docherty A, Harrison E, Green C, Hardwick H, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv. 2020;4(30):1–21